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Summary renal failure may occur at any age (Parto et al. 1993,
1994).
Lysinuric protein intolerance (LPI) is an autosomal re- LPI patients excrete large amounts of cationic amino
cessive disease characterized by defective transport of acids into the urine, whereas the corresponding plasma
cationic amino acids and by hyperammonemia. Linkage concentrations are often subnormal. The molecular
analysis in 20 Finnish LPI families assigned the LPI gene mechanisms leading to the clinical symptoms and signs
locus to the proximal long arm of chromosome 14. Re- of LPI have remained uncharacterized, and the gene lo-
combinations placed the locus between framework cus and the gene itself are unknown.
markers D14S72 and MYH7, a 10-cM interval in which The ﬁrst patients with LPI were described in Finland
the markers D14S742, D14S50, D14S283, and TCRA in 1965 (Perheentupa and Visakorpi 1965). The disease
showed no recombinations with the phenotype. The shows worldwide distribution, but excess cases are
phenotype was in highly signiﬁcant linkage disequilib- known, in Finland (33 families), southern Italy (Incerti
rium with markers D14S50, D14S283, and TCRA. The et al. 1993), and Japan (Kato et al. 1984).
strongest allelic association obtained with marker Since three cationic amino acid–transporter proteins
TCRA, resulting in a Pexcess value of .98, suggests that encoded by two genes have been described (Yoshimoto
the LPI gene locus lies in close proximity to this marker, et al. 1991; Closs et al. 1993a, 1993b), we ﬁrst applied
probably within a distance of õ100 kb. the candidate-gene approach to map the LPI gene. Link-
age studies, with ﬂanking microsatellite markers, ex-
cluded both hCAT-1 and hCAT-2 (Lauteala et al., in
Introduction press) as the mutated gene in LPI. The random-mapping
approach, with the use of highly informative microsatel-
Lysinuric protein intolerance (LPI; MIM 222700) is an lite markers in samples from 18 LPI patients and 48 of
autosomal recessive disease in which transport of the their healthy family members, localized the gene causing
cationic amino acids lysine, ornithine, and arginine is LPI to the proximal part of the long arm of chromosome
defective at the basolateral (antiluminal) membranes of 14. Linkage-disequilibrium data suggest that one
epithelial cells in the intestine (Desjeux et al. 1980; Ra- founder mutation is responsible for the majority of the
jantie et al. 1980) and in the renal tubules (Rajantie et LPI cases in the Finnish population.
al. 1981; Simell 1995). Through unexplained mecha-
nisms, the transport defect also leads to hyperammo- Families, Material, and Methods
nemia after high-protein meals. The clinical signs of LPI
Familiescomprise failure to thrive, vomiting, growth retardation,
and muscular hypotonia. Episodes of stupor may occur For the initial screening, two generations of 10 Finnish
LPI families and three generations of 1 family were cho-after high-protein meals, but strong protective aversion
to dietary protein develops usually at an early age. The sen. After linkage had been conﬁrmed, two generations
of 9 additional families were included. Altogether, thepatients show hepatosplenomegaly and osteoporosis.
Potentially fatal interstitial lung disease and progressive linkage study consisted of samples from 27 patients with
LPI and from 77 healthy family members (ﬁg. 1). Ten
additional families with a single LPI child were included
in the linkage-disequilibrium calculations. The birth-Received December 10, 1996; accepted for publication March 10,
1997. places of the grandparents of the patients were distrib-
Address for correspondence and reprints: Dr. Tuija Lauteala, De- uted unevenly throughout Finland (ﬁg. 2). Diagnosis of
partment of Medical Genetics, University of Turku, Kiinamyllynkatu LPI in all index patients was conﬁrmed by clinical evalu-
10, SF-20520, Turku, Finland.
ation; by documentation of increased urinary excretion 1997 by The American Society of Human Genetics. All rights reserved.
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Figure 1 Pedigrees of the 20 Finnish LPI multiplex families used in the linkage study. The alleles in loci D14S742, D14S50, D14S283,
and TCRA are given for each individual.
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10-ml volume, by use of 37.5 ng of genomic template,
2.0 pmol of each primer, 0.6–1.0 unit of DNA polymer-
ase, 200 mM of each nucleotide, and 1 ml of standard
buffer. Ampliﬁcation was performed in an MJ Research
PTC-100 thermal cycler for 27–35 cycles at 94C for
30–60 s; annealing was performed at different tempera-
tures, depending on the primers, for 30–60 s; and exten-
sion was performed at 72C for 30–60 s. In the ﬁrst
cycle, denaturation was performed for 4–5 min, and
extension was performed at 72C for 6 min. The ampli-
ﬁed fragments were separated by use of 6% polyacryl-
amide–7 M urea sequencing gels. Approximately one-
third of the markers were run and were analyzed with
an ABI Prism 377 automatic sequencer.
Linkage Analysis
Linkage analyses were performed with the LINKAGE
program package (Lathrop et al. 1984), by use of
MLINK for pairwise LOD scores and the VITESSE
(O’Connel and Weeks 1995) program package for
multipoint analysis. VITESSE allows fast multipoint
analyses with highly polymorphic markers, through the
use of the computationally efﬁcient so-called fuzzy-in-
heritance algorithm. All pairwise and multipoint calcu-
lations were performed under the assumptions of no
sex difference and complete penetrance and with the
published allele frequencies in the CEPH pedigrees
(Ge´ne´thon 1996), or, if the allele frequencies were not
Figure 2 Distribution of birthplaces of the grandparents of the available, they were calculated (by use of D14S742)
Finnish LPI families from the families in this study. The order and distances
and the sex-speciﬁc map differences of the loci on the
ﬁxed-marker map were computed by the CILINK pro-
ornithine; by increased serum ferritin and lactate dehy- gram, by use of the available data in the CEPH v.8
drogenase values; and by postprandial hyperammo- database (Fondation Jean DAUSSET–CEPH 1996) for
nemia. a total of 40 CEPH reference families, combined with
the data from the 20 LPI families.
Samples
Linkage-Disequilibrium AnalysisDNA was extracted from peripheral blood, from Ep-
stein-Barr virus–transformed lymphoblast cell lines or The Luria-Delbru¨ck formula (Ha¨stbacka et al. 1992;
from ﬁbroblast cell lines, by use of standard protocols. de la Chapelle 1993; Lehesjoki et al. 1993) was used to
estimate genetic distance between the closest markers
Markers and the major LPI locus, with the assumption that the
number of generations (g) since the introduction of theThe microsatellite markers were provided by the Nor-
dic Genome Resource Center (Uppsala) or were pur- ancestral chromosome is 50; the mutation rate (m) of
the LPI locus is 1006, and the LPI gene frequency (q) ischased from Isogen Bioscience. Some markers were syn-
thesized according to published primer sequences .008 (when the population in the eastern and northern
parts of Finland, where the disease is most prevalent, is(Gyapay et al. 1994; Dib et al. 1996). Polymorphic mi-
crosatellite markers were analyzed by use of PCR and considered). Allelic excess was calculated by use of the
equation Pexcess Å (Paffected 0 Pnormal) / (1 0 Pnormal). Here,polyacrylamide-gel electrophoresis. PCR was performed
in a 25-ml volume, by use of 100 ng of genomic DNA Pnormal is the frequency of the selected allele at the marker
locus, in normal chromosomes, and Paffected is the higheras a template, 3.6 pmol of each primer, 0.04 mCi of a32P-
dCTP, the manufacturer’s suggested volume of standard frequency of the same allele in chromosomes carrying
the disease mutation. The u value was calculated bybuffer and dNTP (Finnzymes or Promega), and 1.0 unit
of DNA polymerase (Finnzymes or Promega). When use of the formula Pexcess Å (1 0 mgq01)(1 0 u)g, where
(10 mgq01) denotes the proportion of LPI chromosomesﬂuorescent primers were used, PCR was performed in a
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Table 1
Pairwise LOD Scores between the LPI Locus and Nine Marker Loci
LOD SCORE AT u Å
MARKER 90% CONFIDENCE
LOCUS .00 .001 .01 .05 .10 .20 .30 Zmax umax LIMITS
D14S261 0 03.25 .57 2.55 2.74 2.03 1.07 2.76 .09 . . .
D14S1023 0 0.17 1.87 3.01 3.00 2.16 1.13 3.08 .07 .01 õ u õ .21
D14S72 0 1.50 3.36 4.08 3.79 2.61 1.36 4.08 .05 .007 õ u õ .16
D14S742 5.82 5.81 5.65 4.94 4.09 2.53 1.24 5.82 .00 .00 õ u õ .06
D14S50 4.02 4.01 3.91 3.45 2.88 1.82 .91 4.02 .00 .00 õ u õ .09
D14S283 6.91 6.89 6.75 6.07 5.17 3.36 1.72 6.91 .00 .00 õ u õ .06
TCRA 5.90 5.89 5.82 5.29 4.48 2.80 1.34 5.90 .00 .00 õ u õ .07
MYH7 0 02.00 .04 1.38 1.69 1.43 .82 1.70 .11 . . .
D14S64 0 2.98 3.85 3.96 3.52 2.36 1.23 4.04 .03 .001 õ u õ .14
carrying the same ancestral mutation (Lehesjoki et al. (with a {1-LOD-unit support interval of 2.7–8.6 cM)
and TCRA, respectively (ﬁg. 4).1993).
Linkage DisequilibriumResults
Linkage-disequilibrium mapping is based on the ob-
Linkage Analysis servation that affected chromosomes descending from a
common ancestral mutation show a distinctive haplo-A total of 317 microsatellite markers randomly spread
type in the immediate vicinity of the gene, reﬂecting thein all autosomes were analyzed in the primary families
haplotype of the ancestral chromosome. We thereforeuntil highly promising LOD scores (ú3) eventually were
tested for linkage disequilibrium in LPI families, withobtained with the microsatellite marker GATA74E02,
the completely linked markers D14S742, D14S50,deﬁning the locus D14S742 on the long arm of chromo-
D14S283, and TCRA. The alleles of these markers, assome 14, near the centromere. No obligatory recombi-
well as allele distribution in LPI and non-LPI chromo-nation events were found between the LPI locus and this
marker. Pairwise linkage analysis revealed a maximum
LOD score (Zmax) of 4.40 (u Å .00), for the initial mate-
rial from 11 LPI families. Consequently, new markers
from this region were analyzed, and linkage was con-
ﬁrmed with six other microsatellite markers (for LOD
scores in pairwise linkage analyses between the LPI locus
and the chromosome 14 markers, see table 1). No oblig-
atory recombinants were observed between the LPI locus
and the loci D14S742, D14S50, D14S283, and TCRA.
Pairwise linkage analysis revealed Zmax values of 5.82,
4.02, 6.91, and 5.90, respectively, at u Å .00 for each
of the four markers.
Recombinations with the proximal marker D14S72
and the distal marker MYH7 preliminarily deﬁned the
genomic region harboring the LPI locus within a 10-
cM chromosomal region on a sex-averaged genetic map.
The 9-point ﬁxed-marker map based on the combined
CEPH-LPI data revealed no signiﬁcant sex-speciﬁc dif-
ferences (data not shown). The best-supported order and
Figure 3 The order and estimated sex-averaged distances (inthe estimated sex-averaged distances (in cM) between
cM) between the markers showing linkage to the LPI locus. The best-the analyzed markers are shown in ﬁgure 3. By the com-
supported sex-averaged 9-point order is shown. The odds that thisbination of information obtained by use of markers
order is correct are at least 2.6 1 104 better than those of the other
D14S72, D14S742, D14S50, D14S283, TCRA, and 9-point orders (excluding pairs with no recombinants) produced by
MYH7, in multipoint analyses, the highest LOD scores pairwise inversion of all loci. No sex differences, as estimated in the
study by Hellsten et al. (1993), could be shown within this map region.of 9.32 and 9.31 were measured at markers D14S283
/ 9a2a$$ju06 05-27-97 14:46:46 ajhga UC-AJHG
1483Lauteala et al.: LPI Gene Maps to Chromosome 14
somes, are shown in table 2. Allele 4 of marker TCRA
was present in 60 (98.4%) of the 61 LPI chromosomes,
which is in contrast with its presence in 22 (35.5%) of
the 62 non-LPI chromosomes. Similarly, allele 6 of
marker D14S283 was present in 57 (93.6%) of the 61
LPI chromosomes and in 14 (22.6%) of the 62 non-LPI
chromosomes. The marker alleles on the chromosomes
carrying the LPI mutation also were distributed nonran-
domly at loci D14S50 and D14S742. The Pexcess values
for the loci D14S742, D14S50, D14S283, and TCRA
were .47, .76, .92, and .98, respectively (table 2). The
estimated genetic region showing allelic association with
the LPI locus spans 1.7 cM (ﬁg. 3). To further estimate
the distance between the disease and the marker loci,
we applied a modiﬁed Luria-Delbru¨ck method. When
50 generations of expansion were assumed, a mutation
frequency of 1006 for the LPI locus and an LPI gene
frequency of .008 resulted in genetic-distance estimates
of 0.04 cM, 0.17 cM, and 0.54 cM, for the loci TCRA,
D14S283, and D14S50, respectively (ﬁg. 5). In the LPI
Figure 5 Luria-Delbru¨ck-based analysis of the location of thechromosomes, ten different haplotypes were detected
LPI gene, with regard to marker loci showing no recombinations inwith four markers (D14S742, D14S50, D14S283, and
linkage analysis. Genetic-distance estimates are shown as a function
TCRA), but only ﬁve haplotypes were detected when of the number of generations. The 95% conﬁdence interval for TCRA
the alleles of the closest markers, D14S283 and TCRA, (lower limit at 0) is based on the sampling error for chromosomes.
were used. The haplotype x–y–6–4 was present in 57
(93.4%) of the 61 LPI chromosomes but in only 5
(8.8%) of the 57 non-LPI chromosomes. The haplotype 1–5–6–4 was carried by 31 (50.8%) of the 61 LPI
chromosomes and by 2 (3.5%) of the 57 non-LPI chro-
mosomes (table 3). Haplotype x–y–6–4 homozygosity
was found in 34 (91.9%) of the 37 LPI patients.
Discussion
The gene for LPI was assigned to the proximal part of
chromosome 14 (14q11-13), by use of linkage analysis
based on random screening of the autosomal genome.
The closest ﬂanking markers, D14S72 on the centro-
meric side and MYH7 on the telomeric side, deﬁned an
interval of Ç10 cM. Strong linkage disequilibrium, with
markers TCRA, D14S283, and D14S50, was present
in a genomic region of 1.7 cM, and, furthermore, the
application of the Luria-Delbru¨ck-based formula sug-
gested that the distance between the closest marker
(TCRA) and the LPI locus is only 0.04 cM. The results
are completely consistent with autosomal recessive in-
heritance and full penetrance, in agreement with pre-
viously published conclusions based on segregation pat-
terns and on careful clinical evaluation. We found no
evidence of genetic heterogeneity, suggesting that, atFigure 4 Seven-point linkage analysis between the LPI locus and
six marker loci. The sex-averaged distances between markers on the least in Finland, the disease is caused by mutations at a
horizontal axis are based on combined data from the LPI and CEPH single locus or at closely related loci. It remains to be
families. Locus D14S72 was selected as a starting point for the map. determined if LPI families from other countries show
The family data include 20 Finnish families with more than one child.
evidence of mapping to the same region.The Zmax and the corresponding map location were 9.3 and 6.1 cM,
Our results are in line with previous linkage studiesrespectively, with a {1-LOD-unit support interval of 2.7–8.6 cM.
The centromere is to the left. of recessive disorders in the isolated population of Fin-
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Table 2
Distribution of Alleles of TCRA, D14S283, D14S742, and D14S50, in LPI and Non-LPI Chromosomes
TCRA D14S283
No. (%) of No. (%) of
ALLELE LPI Non-LPI Pexcess LPI Non-LPI Pexcess
1 1 (1.6) 15 (24.2) 0 1 (1.6)
2 0 10 (16.1) 0 9 (14.5)
3 0 3 (4.8) 1 (1.6) 14 (22.6)
4 60* (98.4) 22 (35.5) .98 1 (1.6) 9 (14.5)
5 . . . . . . 0 10 (16.1)
6 . . . . . . 57* (93.6) 14 (22.6) .92
7 . . . . . . 1 (1.6) 1 (1.6)
8 . . . . . . 0 2 (3.2)
9 0 12 (19.4) 0 2 (3.2)
. . . . . . 1 (1.6) 010
Total 61 62 61 62
D14S50 D14S742
1 1 (1.6) 9 (14.3) 36* (58.1) 17 (27.0) .47
2 4 (6.6) 26 (41.3) 17 (32.3) 24 (38.1)
3 4 (6.6) 6 (9.5) 3 (4.8) 17 (27.0)
4 2 (3.2) 6 (9.5) 2 (3.2) 5 (7.9)
5 50* (82.0) 16 (25.4) .76 . . . . . .
. . . . . . 1 (1.6) 06
Total 61 63 59 63
* P õ .001.
land and again exemplify the power of linkage-disequi- application of the Luria-Delbru¨ck formula, originally
developed to analyze mutations in rapidly growing bac-librium mapping in the study of such populations. Ap-
proximately 30 recessive diseases (called ‘‘the Finnish terial populations, has been considered justiﬁed for the
study of isolated human populations as well. Dia-disease heritage’’; Norio et al. 1973) are exceptionally
common in the Finnish population. The genes for at strophic dysplasia was a good example for the use of
linkage-disequilibrium mapping in the Finnish popula-least 20 of these diseases have been mapped to a speciﬁc
locus (Hellsten 1995). In six diseases (progressive myo- tion: Luria-Delbru¨ck-based analysis predicted that the
diastrophic dysplasia gene lies Ç64 kb from the locusclonus epilepsy [Pennacchio et al. 1996], diastrophic
dysplasia [Ha¨stbacka et al. 1994], choroideremia [San- of the closest marker, CSF1R. When the diastrophic
dysplasia gene subsequently was cloned, its location waskila et al. 1992], infantile neuronal ceroid lipofuscinosis
[Vesa et al. 1995], hypergonadotropic ovarian dysgene- 70 kb from CSF1R (Ha¨stbacka et al. 1992, 1994).
The age of the ancestor mutation may be extrapolatedsis [Aittoma¨ki et al. 1995], and congenital chloride diar-
rhea [Ho¨glund et al. 1996]), the genes have been cloned from the distribution of the grandparents’ birthplaces in
Finland or from the size of the genetic region showingby use of the positional cloning strategy. For the last four
diseases listed above, the founder mutation has been linkage disequilibrium. In the diastrophic dysplasia anal-
ysis, the number of generations was assumed to be 100.described further. For four other diseases for which pro-
tein data was available (aspartylglucosaminuria [Ikonen This estimate was based on the geographical distribution
of the birthplaces of the grandparents, in the so-calledet al. 1991], hereditary fructose intolerance [Cross et
al. 1988], gyrate atrophy of the choroid and the retina earlier settlement areas in the southern and central parts
of the country. In the LPI families, the distribution of[Mitchell et al. 1989], and nonketotic hyperglycinemia
[Kure et al. 1992]), the gene was cloned by use of the the grandparents’ birthplaces in the southeastern and
northern parts of the country—that is, both the olderfunctional cloning principle, followed by detection of
the prevalent mutations. and recent settlement areas—supports the estimate of
Ç50 generations as the age of the mutation. The geneticSince its founding 100–200 generations ago, the pop-
ulation of Finland has grown in isolation. Therefore, region of 1.7 cM that is in strong linkage disequilibrium
/ 9a2a$$ju06 05-27-97 14:46:46 ajhga UC-AJHG
1485Lauteala et al.: LPI Gene Maps to Chromosome 14
follicle-stimulating hormone receptor gene causes hereditaryTable 3
hypergonadotropic ovarian failure. Cell 82:959–968
Distribution of Combined Haplotypes for the D14S742–D14S50– Closs EI, Albritton LM, Kim JW, Cunningham JM (1993a)
D14S283–TCRA Loci, in LPI and Non-LPI Chromosomes Identiﬁcation of a low afﬁnity, high capacity transporter of
cationic amino acids in mouse liver. J Biol Chem 268:7538–
NO. (%) OF
7544
Closs EI, Lyons R, Kelly C, Cunningham JM (1993b) Charac-LPI Non-LPI
terization of the third member of the MCAT family of cat-HAPLOTYPE [n Å 61] [n Å 57]
ionic amino acid transporters. J Biol Chem 268:20796–
1–5–6–4 31 (50.8) 2 (3.5) 20800
x–5–6–4 48 (78.7) 3 (5.3) Collins A, Teague J, Keats BJ, Morton NE (1996) Linkage
x–y–6–4 57 (93.4) 5 (8.8) map integration. Genomics 36:157–162
Others 4 (6.6) 52 (91.2) Cross N, Tolan D, Cox T (1988) Catalytic deﬁciency of human
aldolase B in hereditary fructose intolerance caused by a
common missense mutation. Cell 53:881–885
Davis MM, Bjorkman PJ (1988) T-cell antigen receptor genesalso supports evidence of a relatively high number of
and T-cell recognition. Nature 334:395–402generations since expansion of the LPI mutation. The
de la Chapelle A (1993) Disease gene mapping in isolatednumber of generations strongly inﬂuences the distance
human populations: the example of Finland. J Med Genet
estimation (ﬁg. 5). If the number of generations since 30:857–865
the founding of the LPI mutation is set to be 20 instead Desjeux J-F, Rajantie J, Simell O, Dumontier A-M, Perheen-
of 50, the distance between the LPI and TCRA loci tupa J (1980) Lysine ﬂuxes across the jejunal epithelium in
would increase from 0.04 cM to 0.12 cM. lysinuric protein intolerance. J Clin Invest 65:1382–1387
The critical region harboring the LPI locus has three Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A,
Millasseau P, et al (1996) A comprehensive genetic map ofknown gene assignments, TCRA, CTLA1, and TRP1
the human genome based on 5,264 microsatellites. Nature(Morton et al. 1992; Collins et al. 1996). None of these
380:152–154genes has any known amino acid–transport function.
Fondation Jean DAUSSET–CEPH (1996) http://wwwTRCA is a large 97.6-kb region containing the human
.cephb.frT cell–receptor a and d polypeptide-chain coding re-
Ge´ne´thon (1996) http://www.genethon.frgions. T cell antigen receptor polypeptides (a, b, g, and
Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Milas-
d) form two different heterodimers, ab and gd. The func- seau P, Bernardi G, et al (1994) The 1993–1994 Ge´ne´thon
tion of T cell receptor ab is well established in antigen human genetic linkage map. Nat Genet 7:246–339
recognition, but less is known about the gd receptor Ha¨stbacka J, de la Chapelle A, Kaitila I, Sistonen P, Weaver A,
(Davis and Bjorkman 1988; Koop et al. 1994). Some Lander E (1992) Linkage disequilibriummapping in isolated
LPI patients have associated immunological abnormali- founder populations: diastrophic dysplasia in Finland. Nat
Genet 2:204–211ties, but a clear T cell defect is not a feature of the disease
Ha¨stbacka J, de la Chapelle A, Mahtani MM, Clines G, Reeve-(Nagata et al. 1987). TRP1 is a tRNA proline 1 (Mitchell
Daly MP, Daly M, Hamilton BA, et al (1994) The dia-et al. 1991). The third gene in this region, CTLA1, codes
strophic dysplasia gene encodes a novel sulfate transporter:for cytotoxic T-lymphocyte–associated serine esterase 1
positional cloning by ﬁne-structure linkage disequilibrium(Heusel et al. 1991). Whether any of these genes is the
mapping. Cell 78:1073–1087disease-causing gene in LPI remains to be seen. If not,
Hellsten E (1995) Positional cloning of the infantile ceroid
the assignment of the critical LPI region to a chromo- lipofuscinosis gene. PhD thesis, National Public Health In-
somal area of õ100 kb provides a good starting point stitute, Helsinki
for physical cloning and gene identiﬁcation. Hellsten E, Vesa J, Speer MC, Ma¨kela¨ T, Ja¨rvela¨ I, Alitalo K,
Ott J, et al (1993) Reﬁned assignment of the infantile neu-
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